TYROSINAMIDE, L-

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C9H12N2O2
Molecular Weight	180.2038
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

N[C@@H](CC1=CC=C(O)C=C1)C(N)=O

InChI

InChIKey=PQFMNVGMJJMLAE-QMMMGPOBSA-N

InChI=1S/C9H12N2O2/c10-8(9(11)13)5-6-1-3-7(12)4-2-6/h1-4,8,12H,5,10H2,(H2,11,13)/t8-/m0/s1

HIDE SMILES / InChI

Approval Year

PubMed

Title	Date	PubMed
Glycan labeling strategies and their use in identification and quantification.	2010-08	20225063
Inhibition of Ser/Thr phosphatases induces capacitation-associated signaling in the presence of Src kinase inhibitors.	2010-03-12	20068039
Design strategies of fluorescent biosensors based on biological macromolecular receptors.	2010	22205872
Noncompetitive fluorescence polarization aptamer-based assay for small molecule detection.	2009-09-01	19630421
Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers.	2009-07	19304320
Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474.	2009-03	19029224
Synthesis, spectroscopic and structural elucidation of tyrosinamide hydrogensquarate monohydrate.	2009-02	18317871
Electropolymerized tyrosine-based thin films: selective cell binding via peptide recognition to novel electropolymerized biomimetic tyrosine RGDY films.	2009-01-01	18926794
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.	2008-09-16	19238631
Microcalorimetrics studies of the thermodynamics and binding mechanism between L-tyrosinamide and aptamer.	2008-05-29	18457441
Physiological variations of stem cell factor and stromal-derived factor-1 in murine models of liver injury and regeneration.	2008-03	18290773
CE with electrochemical detection for investigation of label-free recognition of amino acid amides by guanine-rich DNA aptamers.	2007-08	17674419
Antineoplastic agents. 515. Synthesis of human cancer cell growth inhibitors derived from 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene.	2005-08	16124759
NF-kappaB pathway protects cochlear hair cells from aminoglycoside-induced ototoxicity.	2005-03-01	15672440
Influence of alkyl group on amide nitrogen atom on fluorescence quenching of tyrosine amide and N-acetyltyrosine amide.	2004-10-01	15381308
Enzymatic copolymerization alters the structure of unpolymerized mixtures of the biomimetic monomers: the amphiphilic decyl ester of L-tyrosine and L-tyrosineamide--an AFM investigation of nano- to micrometer-scale structure differences.	2004-09-14	15360300
Immobilized DNA aptamers as target-specific chiral stationary phases for resolution of nucleoside and amino acid derivative enantiomers.	2004-02-15	14961733
Chemolabile cellular microarrays for screening small molecules and peptides.	2004	15384424
Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides.	2003-02-13	12570374
Probing the binding specificity of C-type lectins in vivo.	2003	14579569
Spectroscopic properties of tyrosyl radicals in dipeptides.	2002-05-15	11996592
In vitro selection of DNA aptamers that bind L-tyrosinamide.	2001-10	11557341

Patents

Name

Type

Language

TYROSINAMIDE, L-

Common Name

English

AMIDATED L-TYROSINE

Preferred Name

English

BENZENEPROPANAMIDE, .ALPHA.-AMINO-4-HYDROXY-, (.ALPHA.S)-

Systematic Name

English

TYROSINAMIDE

Common Name

English

TYRN

Common Name

English

L-TYROSINE AMIDE

Common Name

English

(S)-2-AMINO-3-(4-HYDOXYPHENYL)PROPANAMIDE

Systematic Name

English

TYROSINE AMIDE

Common Name

English

L-TYROSINAMIDE

Common Name

English

Code System Code Type Description

CAS

4985-46-0